Literature DB >> 36220983

Association of HERPUD1 genetic variant rs2217332 with age-related macular degeneration and polypoidal choroidal vasculopathy in an Indian cohort.

Lakshmi Priyankka Alagappan1,2, Yazhini Ramaswamy1,3, Deepak Kumar Sundaramoorthy1,4, Joshitha Bhaskar1, Sripriya Sarangapani1, Parveen Sen5, Rajiv Raman5, Muna Bhende5, Sinnakaruppan Mathavan6.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) are sister diseases and have several similar clinical features and still have few genetic differences. The association of HERPUD1 (homocysteine inducible ER protein with ubiquitin like domain 1) gene variant rs2217332 with PCV is known; however, such association with AMD has not been reported in the Indian population. We analyzed the association of rs2217332 with PCV and AMD to identify the preferential association of this variant with these diseases.
METHODS: This is a population-based case-control study consisting of 422 patients (129 AMD cases; 101 PCV cases, 192 healthy controls) recruited from the vitreoretinal clinic Sankara Nethralaya. The sample size for the study was calculated using appropriate power calculation methods. Genotype was determined using PCR-based Sanger sequencing. The SPSS V23.0 statistical package tool was used to calculate chi-square and ROC to determine the association of rs2217332 with control, AMD, and PCV.
RESULTS: Here, we report for the first time the association of this genetic variant (rs2217332) with AMD and PCV in the Indian population. The case-control study shows a significant association of this SNP with PCV (P value = 0.002); however, this variant is not significantly associated with AMD (P value = 0.602). Comparison between AMD (as control) and PCV (as case) also showed significant association of the SNP with PCV (P value = 0.02). Minor allele A conferred to increase the risk of PCV.
CONCLUSIONS: The study concludes that the genetic variant rs2217332 in HERPUD1 gene is highly significantly associated with PCV and not with AMD in Indian populations.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Age-related macular degeneration; HERPUD1; Polypoidal choroidal vasculopathy; Sanger sequencing; Single nucleotide polymorphism; rs2217332

Year:  2022        PMID: 36220983     DOI: 10.1007/s00417-022-05861-w

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  35 in total

Review 1.  Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?

Authors:  Peep V Algvere; Stefan Seregard
Journal:  Acta Ophthalmol Scand       Date:  2003-10

2.  A hemodynamic model of the pathogenesis of age-related macular degeneration.

Authors:  E Friedman
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

Review 3.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

4.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

5.  Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration.

Authors:  Antje Biesemeier; Tatjana Taubitz; Sylvie Julien; Efdal Yoeruek; Ulrich Schraermeyer
Journal:  Neurobiol Aging       Date:  2014-05-10       Impact factor: 4.673

6.  Metabolic physiology in age related macular degeneration.

Authors:  Einar Stefánsson; Asbjörg Geirsdóttir; Haraldur Sigurdsson
Journal:  Prog Retin Eye Res       Date:  2010-10-15       Impact factor: 21.198

Review 7.  Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.

Authors:  Chui Ming Gemmy Cheung; Timothy Y Y Lai; Paisan Ruamviboonsuk; Shih-Jen Chen; Youxin Chen; K Bailey Freund; Fomi Gomi; Adrian H Koh; Won-Ki Lee; Tien Yin Wong
Journal:  Ophthalmology       Date:  2018-01-10       Impact factor: 12.079

Review 8.  Age-related macular degeneration.

Authors:  Paul Mitchell; Gerald Liew; Bamini Gopinath; Tien Y Wong
Journal:  Lancet       Date:  2018-09-29       Impact factor: 79.321

Review 9.  Early and intermediate age-related macular degeneration: update and clinical review.

Authors:  Alfredo García-Layana; Francisco Cabrera-López; José García-Arumí; Lluís Arias-Barquet; José M Ruiz-Moreno
Journal:  Clin Interv Aging       Date:  2017-10-03       Impact factor: 4.458

Review 10.  Recent developments in age-related macular degeneration: a review.

Authors:  Waseem M Al-Zamil; Sanaa A Yassin
Journal:  Clin Interv Aging       Date:  2017-08-22       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.